Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Algeta concludes manufacture and supply agreements for alpharadin

July 23, 2010

University of Michigan claims new STAT-3 inhibitors

July 23, 2010

Enrollment begins in phase II MM-121 trial in breast cancer

July 23, 2010

Onyx begins phase III carfilzomib combination trial in relapsed multiple myeloma

July 22, 2010

Curis identifies novel CDK inhibitors

July 22, 2010

New PLK-1 inhibitors discovered by Rigel

July 22, 2010

Inotek describes novel PARP inhibitors

July 21, 2010

Aegera reports survival data from phase I AEG-35156 combination trial

July 21, 2010

German scientists disclose new HIF-mediated transcription inhibitors

July 21, 2010

CytRx advances its bafetinib program in oncology

July 21, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...